{
    "guideline": {
        "id": "PA166114461",
        "name": "Annotation of CPIC Guideline for ivacaftor and CFTR",
        "source": "CPIC",
        "version": 61,
        "url": "https://www.pharmgkb.org/guidelineAnnotation/PA166114461",
        "relatedChemicals": [
            {
                "id": "PA165950341",
                "name": "ivacaftor",
                "symbol": null
            }
        ],
        "relatedGenes": [
            {
                "id": "PA109",
                "name": "cystic fibrosis transmembrane conductance regulator",
                "symbol": "CFTR"
            }
        ],
        "recommendation": true
    },
    "recommendations": [
        {
            "id": "PA166298188",
            "name": "Recommendation PA166298188",
            "population": "general",
            "classification": {
                "term": "Moderate",
                "termId": "guidelineStrength:981501931"
            },
            "relatedChemicals": [
                {
                    "id": "PA165950341",
                    "name": "ivacaftor",
                    "symbol": null
                }
            ],
            "text": {
                "id": 1452060790,
                "html": "<p>Use ivacaftor according to the product label</p>\n"
            },
            "implications": [
                "CFTR: An individual diagnosed with cystic fibrosis (CF) and CFTR variants listed in the FDA-approved drug label as being responsive to ivacaftor"
            ],
            "lookupKey": {
                "CFTR": "ivacaftor responsive in CF patients"
            },
            "dosingInformation": false,
            "alternateDrugAvailable": false,
            "otherPrescribingGuidance": false,
            "guidanceLevel": "1"
        },
        {
            "id": "PA166298187",
            "name": "Recommendation PA166298187",
            "population": "general",
            "classification": {
                "term": "Moderate",
                "termId": "guidelineStrength:981501931"
            },
            "relatedChemicals": [
                {
                    "id": "PA165950341",
                    "name": "ivacaftor",
                    "symbol": null
                }
            ],
            "text": {
                "id": 1452060789,
                "html": "<p>Ivacaftor is not recommended</p>\n"
            },
            "implications": [
                "CFTR: An individual diagnosed with cystic fibrosis (CF) and negative for a CFTR variant listed in the FDA-approved drug label as being responsive to ivacaftor."
            ],
            "lookupKey": {
                "CFTR": "ivacaftor non-responsive in CF patients"
            },
            "dosingInformation": false,
            "alternateDrugAvailable": true,
            "otherPrescribingGuidance": false,
            "guidanceLevel": "3"
        }
    ],
    "citations": [
        {
            "pmid": "24598717",
            "title": "Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for ivacaftor therapy in the context of CFTR genotype.",
            "authors": [
                "Clancy J P",
                "Johnson S G",
                "Yee S W",
                "McDonagh E M",
                "Caudle K E",
                "Klein T E",
                "Cannavo M",
                "Giacomini K M",
                "Clinical Pharmacogenetics Implementation Consortium"
            ],
            "journal": "Clinical pharmacology and therapeutics",
            "year": 2014
        }
    ],
    "version": "2024-03-25-16-13"
}